论文部分内容阅读
长期给予结合磷的铝制剂及/或因透析液中含有铝可引起铝在慢性肾衰血透患者中的蓄积。铝负荷过多可引起抗维生素D的骨质软化症、脑病和贫血。在这些患者中,血清铝浓度常增高。但对血透患者测定血清铝的意义和区分有无铝中毒尚不能肯定。 Gilli等发现血清铝浓度不能反应铝摄入的累积量,且无助于判断铝蓄积的危险。Gundy等认为血清铝浓度超过7μmol/L(18.9μg/d1)将提示有铝
Long-term administration of phosphorus-bound aluminum preparations and / or the inclusion of aluminum in the dialysate can cause accumulation of aluminum in patients with chronic renal failure. Aluminum overload can cause anti-vitamin D osteomalacia, encephalopathy and anemia. In these patients, serum aluminum concentrations often increase. However, the determination of serum aluminum in patients with hemodialysis significance and distinction between aluminum is not yet sure. Gilli et al found that serum aluminum concentrations did not reflect the cumulative amount of aluminum intake and did not help determine the risk of aluminum accumulation. Gundy so that serum aluminum concentration over 7μmol / L (18.9μg / d1) will prompt the aluminum